The “Tomorrow Forum” sponsored by Novo Nordisk A/S of Denmark “Young Scientific Talent Development Program” (STEP) was held in Shanghai between April 23 and 24, 2016. Professor Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University, delivered an invited lecture entitled “Pharmacological studies on a small molecule inhibitor of thioredoxin-interacting protein – Practices of innovative research of anti-diabetic drugs” which was well applauded by the audience. Dr. Kezhou Zhang (Vice President) of Novo Nordisk (China) Pharmaceuticals, Inc. attended the event.